Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States.

Zeidan, Amer M; Pollyea, Daniel A; Borate, Uma; Vasconcelos, Alberto; Potluri, Ravi; Rotter, David; Kiendrebeogo, Zephirin; Gaugler, Lona; Prebet, Thomas; Strocchia, Maria; Bonifacio, Gaetano; Chen, Clara

Zeidan, Amer M; Pollyea, Daniel A; Borate, Uma; Vasconcelos, Alberto; Potluri, Ravi; Rotter, David; Kiendrebeogo, Zephirin; Gaugler, Lona; Prebet, Thomas; Strocchia, Maria; Bonifacio, Gaetano; Chen, Clara.

Afiliação

Zeidan AM; Yale University School of Medicine, New Haven, CT, USA. amer.zeidan@yale.edu.
Pollyea DA; Division of Hematology, School of Medicine, University of Colorado, Aurora, CO, USA.
Borate U; Oregon Health & Science University, Portland, OR, USA.
Vasconcelos A; Bristol Myers Squibb, Princeton, NJ, USA.
Potluri R; SmartAnalyst Inc., New York, NY, USA.
Rotter D; SmartAnalyst Inc., New York, NY, USA.
Kiendrebeogo Z; SmartAnalyst Inc., New York, NY, USA.
Gaugler L; Bristol Myers Squibb, Princeton, NJ, USA.
Prebet T; Bristol Myers Squibb, Princeton, NJ, USA.
Strocchia M; Bristol Myers Squibb, Princeton, NJ, USA.
Bonifacio G; Bristol Myers Squibb, Princeton, NJ, USA.
Chen C; Bristol Myers Squibb, Princeton, NJ, USA.

Ann Hematol ; 102(8): 2299, 2023 Aug.

Article em En | MEDLINE | ID: mdl-37341779

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Ann Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google